Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 51.08

-2.1%

3:35 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (5367)	1/9/2002 11:39:59 AM
From: Biomaven	Read Replies (1) of 52153

Ice, You look correct to me - this MEDX trial does indeed seem to be a combo of unapproved products. Personally I believe this is necessary in some situations, so I'm pleased the FDA let them do it. It still remains to be seen at approval time if the FDA will start grumbling about what effect each component is having and demanding additional individual trials of each component. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next